Stay updated with breaking news from Peggi angel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hollings Awards Grants to Spur Cancer Research Projects miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researcher looks at molecular changes for clues to disparities in breast cancer outcomes miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
In this interview, News-Medical talks to a pioneer of glycan imaging, Richard Drake about glycans, their role in maintaining cellular homeostasis, glycopeptide analysis, and method development for glycan imaging. ....
Share this article Share this article CHARLESTON, S.C., March 10, 2021 /PRNewswire/ GlycoPath Inc., the developer of advanced bioanalytical assays based on its proprietary GlycoTyper TM immunoaffinity technology, announced the closing of its seed investment round with Bruker Corporation (Nasdaq: BRKR) as a new minority investor. Financial details were not disclosed. The proprietary GlycoTyper TM glycan profiling technology captures diagnostic glycoproteins from blood using multiplexed antibody slide arrays, followed by direct analysis of the glycans present on each glycoprotein by MALDI-TOF mass spectrometry. Presently, the GlycoTyper TM technology is for research use only. The initial pathology target for GlycoTyper TM, hepatic fibrosis, is currently one of the fastest growing diseases in the US by annual case numbers, and may affect over 100 million people in the US and 1.5 billion individuals worldwide. In addition to providing initial patie ....